Zeniquin 100 mg, 50 Tablets is a broad-spectrum antibiotic for pets like dogs and cats. Zeniquin (marbofloxacin) by Pfizer Animal Health effectively treats a variety of skin, soft tissue, organ, and urinary tract infections.
Marbofloxacin is a synthetic broad-spectrum antibacterial agent from the fluoroquinolone class of chemotherapeutic agents. This fluoroquinolone pet antibiotic tablets work by inhibiting bacterial DNA replication.
The antibiotic for dogs can successfully treat different types of infections in dogs and cats associated with bacteria susceptible to marbofloxacin.
You can order this dog mediation, antibiotic for cats and other pet medications at our pet pharmacy online. Based in Houston, our online drug store understands the importance of pet in your life and offers the best services in discount pet meds.
Cats over 12 months of age
Dogs of small and medium breeds over 8 months of age
Dogs of large breeds over 12 months of age
Dogs of giant breeds over 18 months of age
- Broad spectrum antibiotic for dogs and cats
- Treats skin, soft tissue, organ, and UTI in dogs
- This antibiotic for pet has an excellent safety profile
- Once-a-day dosing and easy-to-swallow film coated antibiotic tablets
Federal law restricts this pet medicine to use by or on the order of a licensed veterinarian.
Federal law prohibits the extra label use of this pet antibiotic medicine in food-producing animals.
Zeniquin (marbofloxacin) pet antibiotic tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin.
Clinical effectiveness was confirmed in bacterial skin and soft tissue infections in dogs and cats and urinary tract infections or UTI in dogs associated with bacteria susceptible to marbofloxacin.
DOSAGE AND ADMINISTRATION:
The recommended dosage for oral administration of this pet med to dogs and cats is 1.25 mg marbofloxacin per lb of body weight once daily, but the dosage may be safely increased to 2.5 mg/lb.
For the treatment of skin and soft tissue infections, Zeniquin tablets should be given for 2-3 days beyond the cessation of clinical signs for a maximum of 30 days. For the treatment of urinary tract infections, Zeniquin antibiotic tablets should be administered for at least 10 days. If no improvement is noted within 5 days of using this dog medicine, the diagnosis should be re-evaluated and a different course of therapy considered.
Compounds (e.g., sucralfate, antacids, and mineral supplements) containing divalent and trivalent cations (e.g., iron, aluminum, calcium, magnesium, and zinc) can interfere with the absorption of quinolones which may result in a decrease in product bioavailability.
Therefore, the concomitant oral administration of quinolones with foods, supplements, or other preparations containing these compounds should be avoided.
Marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect.
Marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age).
Marbofloxacin is contraindicated in cats less than 12 months of age. Marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.
Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures.
Quinolones have been shown to produce erosions of cartilage of weight-bearing joints and other signs of arthropathy in immature animals of various species.
The use of fluoroquinolones in cats has been reported to adversely affect the retina. Such products should be used with caution in cats.
The safety of marbofloxacin in animals used for breeding purposes, pregnant, or lactating has not been demonstrated.
POSSIBLE SIDE EFFECTS OF ZENIQUIN:
Stop giving the Zeniquin antibiotic and seek emergency veterinary medical attention if your pet experiences an allergic reaction that can cause symptoms like difficulty breathing; closing of the throat; swelling of the lips, tongue or face; or hives.
Other less serious side effects may also occur, which includes loss of appetite, vomiting, diarrhea, dizziness, or drowsiness.
Talk to your veterinarian about any side effect experienced by your pet.
This dog medicine is for use in animals only.
Keep out of reach of children.
Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposure.
Individuals with a history of hypersensitivity to fluoroquinolones should avoid this product.
In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight.
Marbofloxacin, pet antibiotic is supplied in 25-mg, 50-mg, 100-mg, and 200-mg scored, coated tablets.
Store this pet antibiotic below 30°C (86°F).
Pfizer Animal Health, Exton, PA 19341, USA. Div. of Pfizer Inc. NY, NY 10017